Latest News

September 2021

The global market for Contract Research Outsourcing is expected to slump by -1.9% in the year 2020 and thereafter recover to reach US$ 72.1 billion by the year 2027 according to the “Contract Research Outsourcing - Global Market Trajectory & Analytics” report.

Moderna Inc. has announced its number one priority as a company is to bring to market an annual single-dose vaccine combining a booster dose against both COVID-19 and flu, which it will always customize and upgrade:


India’s contract research firms have big ambitions and they are beginning to pay off in the global market:


The world's first COVID-19 drug based on human immunoglobulin developed from plasma recovered from COVID-19 patients will enter clinical trials in China:


Over the last 18 months, decentralized clinical trials have been proven to boost enrollment and increase patient diversity, and should be increased:

prweb.com. And this FREE live webinar by AliveCor on Wednesday, September 22, 2021 at 6pm BST | 1pm EDT will cover new ways to capture medical-grade data remotely and securely during decentralized clinical trials.

“Clinical Trials In Crisis: Building on COVID-19’s Lessons Toward A Better Future”: part of the Health Affairs Blog short series, “Envisioning A Transformed Clinical Trials Enterprise For 2030” looking at the US health care system:


The Bill & Melinda Gates Foundation is making a $35m equity investment in Oxford-based privately owned Exscientia Ltd to fund the development of antiviral drugs against SARS-CoV-2 and its variants. Exscientia is making a matching contribution:


The European Medicines Agency (EMA) has published a new handbook to guide trial sponsors in using Europe’s new CTIS trial registry, which will launch at the end of January 2022:


COVID-19 vaccine makers ought to make their approved vaccines available as comparators for clinical trials or risk hobbling the development of more vaccines, say the Coalition for Epidemic Preparedness Innovations (CEPI):


FREE Webinar “Vaccines - Lessons Learnt From The Pandemic” Associate Professor Teresa Lambe, The Jenner Institute, University of Oxford, Co-Developer of Oxford AstraZeneca COVID-19 Vaccine will describe the development, testing and immune readout after vaccination with ChAdOx1 nCOV-19/AZD1222. September 15, 4PM BST |11AM EDT:



Oracle Partner NCC Group

Customer Area